Related Experiment Video
Updated: Feb 11, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Secondary Prevention Strategies for Nonmelanoma Skin Cancer
Abstract:
Skin cancer is the most commonly diagnosed cancer in the United States and has become a major public health problem that continues to grow. Despite numerous initiatives and increased public awareness of the dangers of skin cancer, the incidence of skin cancer continues to rise worldwide. This highlights the need for a critical review of existing skin cancer prevention strategies as a means to determine where targeted efforts may improve patient outcomes. In this article, we review the published literature and evaluate secondary prevention strategies for nonmelanoma skin cancer. Specifically, we examine the existing data on the use of chemopreventive agents for nonmelanoma skin cancer primarily in immunocompetent individuals, but also in organ transplant recipients, the best-studied immunosuppressed population. We also explore investigational therapies proposed for chemoprevention of nonmelanoma skin cancers.
Insights
This review examines secondary prevention strategies for nonmelanoma skin cancer, focusing on chemopreventive agents in immunocompetent and immunosuppressed individuals. It highlights the need for targeted efforts to combat rising skin cancer incidence.
Area of Science:
- Oncology
- Dermatology
- Public Health
Background:
- Skin cancer is a growing global public health concern, with rising incidence despite awareness campaigns.
- Existing skin cancer prevention strategies require critical evaluation to identify areas for improved patient outcomes.
Purpose of the Study:
- To review and evaluate secondary prevention strategies for nonmelanoma skin cancer.
- To examine chemopreventive agents for nonmelanoma skin cancer in immunocompetent and immunosuppressed populations.
Main Methods:
- Systematic review of published literature on nonmelanoma skin cancer secondary prevention.
- Analysis of data on chemopreventive agents, including investigational therapies.
- Focus on both immunocompetent individuals and organ transplant recipients.
Main Results:
- The review synthesizes current data on chemopreventive agents for nonmelanoma skin cancer.
- Effectiveness and application in different patient groups are discussed.
- Investigational therapies are explored for future prevention.
Conclusions:
- There is a critical need to refine secondary prevention strategies for nonmelanoma skin cancer.
- Chemoprevention shows promise, particularly in specific populations.
- Further research into targeted interventions is essential to curb rising skin cancer rates.
More Related Videos
08:16X-ray Visualization of Intraductal Ethanol-based Ablative Infusion for Prevention of Breast Cancer in Rabbit Models
Published on: September 12, 2025
12:57X-Ray Visualization of Intraductal Ethanol-Based Ablative Treatment for Prevention of Breast Cancer in Rat Models
Published on: December 9, 2022
Related Concept Videos
Cancer Prevention
Some...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Secondary Active Transport
Secondary Active Transport
Secondary Healthcare System
Primary and Secondary Growth in Roots and Shoots